2,6-dimethyl-1,4-benzoquinone and Stomach Neoplasms

2,6-dimethyl-1,4-benzoquinone has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dong, Z; Kim, DJ; Laster, K; Liu, K; Lu, B; Ma, X; Xie, X; Zu, X	1

Other Studies

1 other study(ies) available for 2,6-dimethyl-1,4-benzoquinone and Stomach Neoplasms

Article	Year
2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo. Journal of experimental & clinical cancer research : CR, 2020, Jun-09, Volume: 39, Issue:1 Topics: Animals; Apoptosis; Benzoquinones; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Mice; Mice, Nude; Prognosis; Protein Kinase Inhibitors; Stomach Neoplasms; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2020

Article

Year

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo.

Journal of experimental & clinical cancer research : CR, 2020, Jun-09, Volume: 39, Issue:1

Topics: Animals; Apoptosis; Benzoquinones; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Mice; Mice, Nude; Prognosis; Protein Kinase Inhibitors; Stomach Neoplasms; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020